GB2174609A - Resuscitator/ventilator - Google Patents

Resuscitator/ventilator Download PDF

Info

Publication number
GB2174609A
GB2174609A GB08610169A GB8610169A GB2174609A GB 2174609 A GB2174609 A GB 2174609A GB 08610169 A GB08610169 A GB 08610169A GB 8610169 A GB8610169 A GB 8610169A GB 2174609 A GB2174609 A GB 2174609A
Authority
GB
United Kingdom
Prior art keywords
patient
valve
primary gas
mixer
flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08610169A
Other versions
GB8610169D0 (en
GB2174609B (en
Inventor
Norman Stewart Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pneupac Ltd
Original Assignee
Pneupac Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858511170A external-priority patent/GB8511170D0/en
Application filed by Pneupac Ltd filed Critical Pneupac Ltd
Priority to GB08610169A priority Critical patent/GB2174609B/en
Publication of GB8610169D0 publication Critical patent/GB8610169D0/en
Publication of GB2174609A publication Critical patent/GB2174609A/en
Application granted granted Critical
Publication of GB2174609B publication Critical patent/GB2174609B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/12Preparation of respiratory gases or vapours by mixing different gases
    • A61M16/122Preparation of respiratory gases or vapours by mixing different gases with dilution
    • A61M16/125Diluting primary gas with ambient air
    • A61M16/127Diluting primary gas with ambient air by Venturi effect, i.e. entrainment mixers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/1005Preparation of respiratory gases or vapours with O2 features or with parameter measurement
    • A61M16/101Preparation of respiratory gases or vapours with O2 features or with parameter measurement using an oxygen concentrator

Abstract

A portable resuscitator/ventilator device especially intended for emergency use and powered by pressurised primary breathable gas such as oxygen or compressed air from a bottle 14 comprises a control unit 10 that outputs primary gas pulses to a patient valve 12 that includes an entrainment mixer 20 for diluting the primary gas with air. The entrainment mixer is selectively operable so that the patient valve delivers primary gas or air-diluted primary gas as required. The control unit includes a flexed value flow- control restrictor 18 that passes a required tidal volume of primary gas for undiluted delivery to the patient and the impedance of the patient valve is arranged to increase when the entrainment mixer is operational so that flow of the primary gas is automatically reduced to provide the required tidal volume of air-diluted primary gas without wastage of primary gas or any adjustment of the control unit. <IMAGE>

Description

SPECIFICATION Resuscitator/Ventilator THIS INVENTION concerns resuscitator/ventilator devices of the type powered by pressurised breathable gas such as compressed air or oxygen and adapted to deliver pulses of this gas to the respiratory passages of a patient to accomplish forced ventilation of the lungs in cases of respiratory failure or impairment.
Such devices, hereinafter termed, shortly, "gas-powered resuscitator/ventilator devices" typically iriclude a control unit that generates the required pulses of breathable gas, and a socalled "patient valve" that is connected to the control unit by a flexible conduit or hose and that is associated with an oronasal mask or tracheal intubation device, this patient va ve operating to connect the respiratory passages of the patient to the control unit during an inhalation phase, and to an exhaust outlet during the exhalation phase.Devices of this type in compact portable form are widely available to Emergency Services such as ambulance crews for resuscitation and short-term ventilation purposes, the devices in this form being almost invariably designed to deliver pulses of pure oxygen from a compressed oxygen source because not only is pure oxygen ventilation beneficial for short-term application such as in resuscitation, but its use in this way permits the control unit and patient valve to be very simple and robust devices, resistant to abuse and easily operated correctly by personnel with a minimum of training. Indeed it is these features of such devices that have led to their increasing use for longer term ventilation as when patients with impaired respiratory function are subject to extended transportation. However, medical opinion is not undivided about the merits of long-term ventilation with pure oxygen.Moreover such devices necesserily have a relatively high rate of oxygen usage so that their long-term use can lead to problems of oxygen source availability.
There is therefore a need to provide a compact and portable gaspowered resuscitator/ventilator device with the facility to deliver to a patient selectively pure oxygen oxygen diluted with air, or air. An objective of the present invention is to meet this need but without significantly affecting the standards of robustness, portability, resistance to abuse and ease of operation at present available in devices capable only of delivering pure oxygen.
The type of gas-powered resuscitator/ventilator device here of interest divides into two main sub-types: the sub-type characterised by a low-force patient valve and that incorporates a control unit that generates pu ses at a low pressure appropriate for direct delivery to the patient; and the sub-type characterised by a high-force patient valve and that incorporates a control unit that generates either high-pressure pulses or relatively low-pressure pulses that are only a small amount higher in pressure than the pulses to be delivered to the patient.The devices having a low-force patient valve use a low impedance (large bore conduit) connection between the control unit and the patient valve and can be vulnerable to ma function in the presence of contamination, whereas the devices having a high-force patient valve can have a high impedance (small bore conduit) connection between the control unit and the patient valve. The high-force patient valve has a number of advantages from the point of view of reliability in addition to its ability to operate with a relatively high impedance connection to the control unit. GB-A1,511,233 and its counterparts disclose a patient valve of this type. For convenience herein, devices having high-force patient valves will be called, shortly, "high-force devices".
Traditionally, in ventilators designed for long-term use in, say, a hospital, dilution of oxygen to a desired breathable gas composition-for instance, a 30/70 oxygen/air mixture having therefore-about 45% oxygen content-is accomplished by use of an entrainment mixer. However, the application of such an entrainment mixer to a gas-powered resuscitator/ventilator of the type of interest is not straightforward because such mixers can be designed to give either a high mixing ratio or high pressure recovery, but not both simultaneously.If, therefore, the mixer is designed to achieve the desired oxygen dilution the pressure recovery will generally be insufficient to allow of the use of a high impedance downstream connection: in other words, if the mixer is incorporated in the control unit, the latter will not be able to output pulses able to drive a high-force patient valve through a highimpedance conduit. In this context "high-impedance conduit" is to be understood as meaning a conduit that at the maximum flow therethrough imposes a pressure drop of more than about 3.5 kPa (0.5 psi).
Accordingly, to maintain the advantages of the high-force device sub-type, an entrainment mixer if used to accomplish oxygen dilution must be located at the patient valve. However this leads to control problems because of the basic requirement, in a resuscitator/ventilator device of the type of interest, to be able to deliver pure oxygen when necessary, e.g. for resuscitation purposes. Thus it must be possible to disable the entrainment mixer, or to substitute a patient valve not having such a mixer, to provide for delivery of pure oxygen when this is required.
Selective disablement of an entrainment mixer at the patient valve, or the facility to exchange patient valves with and without entrainment mixers, respectively, leads to flow regulation problems because flow reguation is normally performed within the control unit by means of a highimpedance restriction that makes the output of the unit independent of the impedance characteristics both of the patient valve and of the conduit connecting the latter to the control unit, and also independent of patient compliance, over a wide range of values. If the flow regulation is set to deliver in accordance with the requirements of pure oxygen ventilation then, when a patient valve having an entrainment mixer is brought into operation to achieve dilution of oxygen delivered by the control unit, the oxygen delivery will be in excess of oxygen requirements and wastage will occur.That is to say, while the device in these circumstances delivers diluted oxygen as desired, its oxygen consumption will remain at the rate corresponding to usage of pure oxygen.
Accordingly it would appear that provision must be made at the control unit for resetting the flow regulation in accordance with the absence or presence at the patient valve of an operative entrainment mixer. This is obviously undesirable in a device that must be used, perhaps under adverse emergency conditions, by personnel with little training and/or who are called upon to use the device infrequently.
However, it has been discovered that it is in fact possible to avoid the apparent need for resetting of flow regulat-on arrangements at the control unit, by giving the patient valve impedance characteristics that affect the flow regulation function, appropriately to reduce oxygen delivery by the control unit, when there is an operative entrainment mixer at the patient valve.
Thus in its broadest aspect, the invention provides a gas-powered resuscitator/ventilator device cornprising a control unit having a highimpedance flow-regulation restriction adapted to output to a patient valve primary gas pulses appropriate for undiluted delivery to a patient, characterised by a patient valve including an entrainment mixer that when operative dilutes primary gas pulses output by the control unit, the patient valve and operative entrainment mixer jointly providing a primary gas flow impedance so related to the impedance of the flow-regulation restriction as to reduce primary gas flow therethrough.
Thus by simple substitution of the re atively low-impedance patient valve that would be appropriate to deliver undiluted primary ga s-e.g. pure oxygen-by the patient valve and operative entrainment mixer combination, the flow-regulation at the control unit is automatically overridden, conveniently to the extent necessary to compensate for the reduced primary gas requirement of the patient valve and operative entrainment mixer combination.
The device of the invention may have two exchangeable patient valves-one of relatively low impedance and adapted to deliver to a patient undiluted primary gas pulses as received from the control unit, and another in cluding a permanently operative entrainment mixer and of appropriately higher impedance-or the device may comprise a single patient valve incorporating an entrainment mixer that may be rendered operative or inoperative as required, by means that cause the impe dance presented to primary gas flow to be appropriately raised when the entrainment mixer is rendered operative.
Thus, in an embodiment of the invention, a gas-powered resuscitator/ventilator device comprises a control unit having a high-impedance flow-regulation restriction adapted to output to a patient valve primary gas pulses appropriate for undiluted delivery to a patient, characterised both by an entrainment mixer at the patient valve and in that the entrainment mixer is associated with a series flow restrictor and a shunt circuit and with ganged valve means oppositely controlling diluent flow to the entrainment mixer and primary gas flow in said shunt circuit respectively.
By means of this arrangement, a required ventilation tidal flow of pure oxygen (the primary gas supplied by the control unit) can be obtained via both of the entrainment device and the shunt circuit in parallel, while the entrainment device is effectively disabled by the valve means preventing flow of diluent into the entrainment mixer. In this operating mode, the primary gas flow impedance at the patient valve will be low, relatively to the flow-regulat-on restriction, so that the output to the patient valve will be substantially independent of changes in downstream compliance.Alternatively, when the entrainment mixer is placed in its operative condition by setting said valve means to allow diluent to enter the entrainment mixer, the shunt circuit is closed by said valve means to prevent by-pass flow of primary gas (oxygen) therethrough, the impedance of the patient valve to primary gas flow being thereby raised to the extent necessary to limit the total flow of oxygen drawn from the control unit.
The restrictor associated with the entrainment mixer may conveniently be constituted by the nozzle thereof, because this arrangement offers the highest available pressure recovery, it being understood that the impedance offered by this restrictor is preferably selected to provide, in combination with the flow-regulation restriction of the control unit, no more than the appropriate flow of primary gas (oxygen) to provide, with dilution, the total ventilation tidal flow volume required by the patient. Thus, the impedance of the shunt circuit and of the mixer and associated restrictor may be so chosen that when the mixer is operative the impedance at the patient valve exceeds that obtaining when the mixer is disabled by an amount such that the primary gas flow to the patient valve is reduced in correspondence with the dilution of the primary gas to maintain a selected delivered gas volume.
While the invention is especially advantageously applicable to resuscitator/ventilator devices of the high-force sub-type to enable the reliability and other advantages of the highforce patient valve to be realised in conjunction with the ability to change, simply, from pure oxygen to diluted oxygen delivery, the invention may also be applied with advantage to devices of the low-force sub-type.
It should be understood that when flow through the shunt circuit is prevented in the operative condition of the entrainment mixer, the effective additional restriction of the primary gas (oxygen) flow path downstream of the control unit not only reduces the oxygen flow to the required value but also raises the oxygen pressure upstream of the entrainment mixer during the passage of a gas pulse, thereby to optimise the operation of the entrainment mixer and to provide a pressure/flow characteristic such that different patient airway resistances and lung compliances will have minima effect upon the tidal flow volume delivered to the patient's lungs.
A resuscitator/ventilator embodying the invention has also the capability of delivering air pulses to a patient to assist breathing in circumstances in which oxygen enrichment of the delivered air is unnecessary or undesirable.
Thus, by substituting a compressed air source for the normal oxygen source and using the entrainment mixer to "dilute" the air pulses thereby output by the control unit, air alone may be delivered. The compressed air source might, for instance, be a low power compressor.
The entrainment mixer may be of any suitable type. However it is preferred to employ an entrainment mixer of the construction described in co-pending Application No.
8609659 (Agent's Ref: P3423GB) that allows the mixer to be of compact format without significant prejudice to its pressure-recovery capabilities.
The invention will be further explained with reference to the accompanying drawings in which: FIGURE 1 is a diagrammatic representation of a typical gas-powered resuscitator/ventilator as currently known; FIGURE 2 is a diagrammatic representation of a gas-powered resusc-tator/ventilator in accordance with one embodiment of the invention; FIGURE 3 is an enlarged schematic representation of the patient valve/entrainment mixer arrangement of the device of Figure 2; FIGURE 4 corresponds with Figure 3 but illustrates an embodiment in which the patient valve is of the low-force type; and FIGURES 5, 6 and 7 illustrate a practical embodiment of a patient valve incorporating the arrangement of Figures 2 and 3, Figure 5 being a part sectional side elevation, Figure 6 a part sectional supply end elevation, and Figure 7 a part sectional underneath plan.
Referring to the drawings, Figure 1 shows the basic components of a gas-powered resuscitator/ventilator device intended to deliver undiluted breathable gas-typically medical ox ygen-from a source thereof to a patient for short-term forced ventilation. The device consists of two main units, a control unit 1 and a patient valve 2 connected by a flexible conduit 3. The arrangement illustrated is that for a device having a control unit that delivers pulses of gas at suitable pressure to a highforce patient valve, the conduit 3 constituting a high impedance connection between the control unit 1 and the patient valve 2 and consisting, for instance, in a flexible small bore hose.
The gas supply, that may for instance be from a cylinder of compressed oxygen and at a pressure in the range 250-600 kPa and typically 400 kPa (2.5-6 bar, typically 4 bar) is conventionally represented at 4 and is connected to a pressure regulator 5 that maintains a suitable output pressure (for instance 250 kPa (2.5 bar)) that is unaffected by variations in the gas supply pressure. The pressure regulator 5 may be external or, as represented, incorporated in the control unit. In either case, the control unit includes a timing unit 6 and associated valve 7 that when the control unit is in operation release suitably timed pulses of gas to a flow control valve 8.
The timing unit 6 may for instance be a gaspowered oscillator, e.g. as disclosed in GB-A1,533,550.
The patient valve 2 may take a variety of forms, its function being to respond to the arrival of a gas pressure pulse over the conduit 3 to duct this pulse to the patient via an oronasal mask or intratracheal tube, while in the interval between such pulses the patient valve establishes communication between the patient and an exhalation part. The particular arrangement conventionally represented is that of a high-force patient valve of the construction described in GB-A-1,511,233, the restrictor shown at 9 being the internal flow path restriction that maintains a pressure differential between the gas pulse inlet and the gas pulse outlet of the valve while gas is flowing through the valve to the patient, thereby reliably to maintain the valve in the condition in which this flow path is open.
In a typical form of the system diagrammatically represented in Figure 1, and in which the control unit 1 is intended to produce relatively low-pressure pulses, the flow control valve 8 is set to produce, at the required oxygen flow rate to deliver a pulse of the required tidal volume, a pressure drop, typically about 50 kPa (.5 bar), that is a high percentage of the output pressure of the pressure regulator 5 so that minor impedance changes downstream of the valve 8, e.g. arising from variations in patient airway resistance and lung compliance, can have very little effect on the overal impedance downstream of the pressure regulator 5 and, hence, on the gas flow to the patient.
Figure 2 illustrates an embodiment of the invention in which the control unit 10 may correspond in construction and arrangement with that of the device shown in Figure 1, comprising a pressure regulator 15 providing, e.g., an output pressure of about 250 kPa (2.5 bar) as in the prior art arrangement of Figure 1, a timing unit 16 and associated valve 17 together with a flow control valve 18. This control unit is intended to draw oxygen from a suitable source conventionally represented at 14 and to output pulses of oxygen via a conduit 13 that may conveniently be a high impedance conduit constituted by a flexible hose of relatively small bore.
In the system of Figure 2, the patient valve represented at 12 includes an entrainment mixer 20 having an associated restrictor 21 in series and conveniently constituted by the nozzle of the mixer 20. The entrainment mixer 20 and restrictor 21 are bridged by a shunt circuit comprising a restrictor 22 and a valve 23 that is ganged with a valve 24 controlling a diluent inlet 25 for the entrainment mixer 20.
The ganged valves 23, 24 are so arranged that when valve 23 is open, valve 24 is closed, and vice versa.
Figure 3 shows, on a larger scale, the theoretical circuit of the patient valve 12 of Figure 2. As in the case of Figure 1, the illustration is that applicable to a patient valve of the high-force form and, depending on the operating condition, either the entrainrnent mixer 20 and its associated restrictor 21 (nozzle) constitute the flow path restriction. between the gas pulse inlet and the gas pulse out et of the valve or these devices with the restrictor 22 in parallel therewith constitute the said flow path restriction, for the purpose described.
In operation of the embodiment of Figures 2 and 3, when the resuscitator/ventilator device is to deliver pure oxygen pulses for forced ventilation of a patient, the ganged valves 23, 24 are set so that the valve 23 is open and the valve 24 is closed. Closure of the valve 24 prevents the entry of diluent (air) to the entrainment mixer 20 so that the pure oxygen pulses from the control unit 10, arriving at the gas pulse inlet 26, divide and flow through the shunt circuit with its restrictor 22 and through the entrainment mixer 20 and its associated restrictor 21 to the patient connection 27.The restrictors 21 and 22 are so sized, in relation to the impedance offered by the flow control valve 18 of the control unit 10, as to provide the requisite small pressure drop for holding the patient valve in its pulsetransmitting condition while passing the required ventilation tidal flow volume of oxygen to the patient. Because the impedance offered by the parallel restrictors 21 and 22 is small compared with that of the valve 18, and because of the non-linearity of the pressure drop/flow relationship of the restrictors 21, 22 and of the valve 18, it is the setting of the latter -that effectively regulates the oxygen flow in this operating mode.
On the other hand, with the ganged valves 23, 24 set so that the valve 23 is closed and the valve 24 is open, the entrainment mixer 20 is enabled to receive diluent through diluent inlet 25, to be entrained in and mixed with the oxygen that passes through the mixer 20 and associated restrictor 2 (only) upon the arrival of an oxygen pressure pulse at the pulse inlet 26.
In this operating mode, because there is no flow in the shunt circuit comprising the restrictor 22, the effective impedance of the flow path between the pulse inlet 26 and the patient connection 27 is raised relative to that obtaining in the same flow path in the operating mode for delivery of pure oxygen to the patient connection 27. The consequence of this is that the oxygen flow in this operating mode is reduced, the non-linearity of the pressure drop/flow relationship for the restrictor 21 and for the valve 18 making the pressure drop at the restrictor 21 the more significant at this reduced flow rate and thus sharply transferring flow control from the valve 18 to the mixer 20 and restrictor 21 combination.
By appropriate choice of impedance values for the mixer 20 and its associated restrictor 2, at the reduced flow rate required when the mixer 20 is operative, therefore, it can be arranged that in this operating mode the effective impedance at the patient valve so exceeds that of the flow control valve 18 as predominantly to control the flow rate at an amount such as to cause the oxygen flow in this mode to be approximately one-third of that in the operating mode in which the device delivers pure oxygen to the patient, while the mixer dilutes this oxygen with about twice its own volume of air to produce the same tidal flow volume as when delivering pure oxygen.
The valve 18 in a typical operational setting is equivalent to a throttle having a diameter of about 1.2mm: in such configuration the restrictor 21 when constituted by the nozzle of the entrainment mixer would have a diameter of about 0.65mm and the restrictor 22 a diameter of about 1.5mm.
Thus, merely by suitable choice of impedance values, at the relevant flow rates, for certain components, the ventilation tidal flow volume required by a patient can be provided either wholly by oxygen or by a mixture of air and oxygen, with the oxygen flow and consumption being automatically reduced in the latter case merely as a consequence of bringing the entrainment mixer 20 into operation by actuation of the ganged valves 23, 24. That is to say, no adjustment of the flow control valve 18 at the control unit 10 is re quired on switching between delivery of pure oxygen, on the one hand, and delivery of diluted oxygen, on the other hand.
Moreover the components providing this selectable gas composition facility are either static (entrainment mixer 20, restrictors 21, 22) or of such simple mechanical form (ganged valves 23, 24) as to impose no reliability or other penalties upon the construction and use of the device in comparison with the equivalent device not having this additional facility.
As noted, the invention is also applicable to devices having low-force patient valves and Figure 4 illustrates the theoretical circuit of the switchable entrainment mixer as applied to such a patient valve. In Figure 4 the low-force patient valve is represented at 30 with its pulse inlet 31, patient connection 32 and exhalation port 33. In applying the invention, an entrainment mixer 34 with associated restrictor 35 and bridged by a shunt circuit 36 is arranged upstream of the pulse inlet 31. The entrainment mixer 34 has a diluent gas inlet 37 controlled by a valve 38 that is ganged with a valve 39 in the shunt circuit 36 so that when the valve 38 is open, the valve 39 is closed, and vice versa.
When the valve 39 is open there is effectively no impedance in the oxygen path to the pulse inlet 31 so that all gas flow control is exercised at the control unit in much the same way as in the arrangements illustrated in Figures 1 and 2. However, when the valve 39 is closed and the valve 38 is open, the impedance of the restrictor 35 appears in the oxygen flow path to the pulse inlet 3 and thus both reduces the oxygen flow while raising the upstream pressure to a value appropriate for correct functioning of the entrainment mixer 34.
In a convenient configuration for such an arrangement, the control unit would be arranged similarly to that of Figures 1 and 2 but with a flow control valve adapted to provide pulses at a pressure of about 0.5 kPa (5mbar) when the valve 39 is open (and valve 38 closed) for delivery of pure oxygen to the patient. With the valve 39 closed (and valve 38 open) for delivery of diluted oxygen, the impedance of the mixer 34 and restrictor 35 (preferably constituted by the nozzle of the mixer) resu ts in the pressure upstream of the restrictor 35 rising to approximately the delivery pressure of the pressure regulator of the control unit-say 250 kPa (2.5 bar) in the typical case.
Figures 5 to 7 illustrate a practical realisation of the invention, in the form of a selectable output patient valve for a resuscitator/ventilator and conforming with the principles described in relation to Figures 2 and 3.
As shown in Figures 5 to 7, this realisation comprises a valve body part 50 defining a cylinder closed at a gas supply end by a cap 51 having an inlet port 52 for connection to a control unit that outputs pulses of primary gas, usually oxygen, in the manner described in relation to Figures 1 and 2. At the opposite, or exhalation end, the body part 50 has its cylinder closed by an annular plug 53 that provides an exhalation port 54 and a seating for a spring 55 within an annular valve seat 56.
The body part 50 is further comprised of a lateral gas transfer stub 57 and a patient connect on stub 58 to receive a connecting tube for an oronasal mask or the like (not shown).
A waisted valve piston 59 is reciprocable within the cylinder of body part 50, being engaged by the spring 55 to be urged towards the gas supply end of the cylinder (to the right as seen in Figure 5) and away from the valve seat 56.
The gas supply end of the cylinder accommodates a pilot assembly comprising a sleeve 60 located in a stepped bore portion of the cylinder and secured to the periphery of a flexible diaphragm 61 the central portion of which is secured to an operating plunger 62 having a spigot portion 63 engaged in a central recess in the piston 59.
The stubs 57 and 58 are interconnected within the body part 50, externally of the cylinder therein. The stub 57 has a connection to the cylinder via a port 64 in the wall of the cylinder and positioned to align with the waist of the piston 59 when the latter has moved to the left, as seen in Figure 5, to engage the valve seat 56. The stub 58, on the other hand, connects with the cylinder via a port 65 positioned to be uncovered by the piston 59 when this is in the position illustrated, thereby to provide communication between the patient connection stub 58 and the exhalation port 54 in this position of the piston.
As so far described, the patient valve is functionally equivalent to the patient valve described in GB-A-1,511,233, differing in detail from the latter in that the piston 59 is driven by the pilot assembly diaphragm 61 in response to a gas pulse at the inlet port 52, rather than by gas acting directly on the piston, and in that gas entering the body part at port 52 reaches the patient connection stub by a restricted flow path external of the piston and cylinder, rather than through a restricted passage in the piston.
Thus, when a gas pulse arrives at port 52, the piston 59 is driven to the left as seen in the drawing, against the thrust of spring 55, to occlude the port 65 and to engage the valve seat 56 so as to iso ate the patient connection stub 58 from the exhalation port 54. Under these conditions the gas pulse passes, by a route to be described, to the gas transfer stub 57 and thence to the stub 58 to flow to the patient and cause forced inhalation by the latter. When gas pulse pressure at the port 52 decays, the spring 55 returns the piston to the illustrated position to re-establish communication between the stub 58 and the exhalation port 54 so that the patient may exhale.
In accordance with the present invention, the gas flow path between the port 52 and the gas transfer stub 57 comprises an entrainment mixer that may be brought selectively into operation in such manner as automatically to adapt the primary gas f ow to the required tidal volume of total supplied breathing gas.
Thus the patient valve further comprises a second body part 70 in the form of a plate that is secured to the body part 50 by bolts, one of which is shown at 71 (Figure 6) and the other of which is not shown but is located to transfix and secure in place the jet block 72, described below, of the entrainment mixer by passing through a bore 73 in the jet block.
The body part 70 has a plenum 74 that engages the gas transfer stub 57, being sealed thereto by an O-ring 75.
The body part 70 defines both a by-pass passage 76 and a mixer bore 77, both of which communicate with the plenum 74. The by-pass passage breaks tangentially into a chamber housing a poppet valve assembly 79 to be described below.
The mixer bore 77 houses the entrainment mixer that is constituted by the jet block 72, a a receiver 80 and a pressure recovery section 81 comprising an insert 82 in the receiver body and having a substantially constant clear bore with steps defined by a succession of sharp-edged grooves. The mixer bore 77 is stepped near the plenum 74 to locate the end of the receiver body and the latter is sealed in the bore 77 by an O-ring 83. The receiver 80 is defined by an axial bore in the receiver body, communicating with an entrainment chamber 84 defined between wings 85 at the end of the receiver body and that serve to locate, by abutment, the jet block 72. The jet block 72 is also sealed in the mixer bore by a pair of O-rings 86 in grooves in the block 72.
An axial jet passage 87 in the jet block extends to intercept a cross bore 88 in a waisted portion of the jet block 72 between the O-rings 86. As noted above, the jet block 72 is secured in the mixer bore 77 by a fixing bolt for the body part 70 extending through the bore 73 in the jet block. This fixing of the jet b ock also secures in place the receiver body that is effectively trapped between the jet block and a step in the mixer bore.
As best seen in Figure 6, the waisted portion and cross bore 88 of jet block 72 communicate with a primary gas passage 89 formed partly in the body part 70 and partly in the end cap 51, this passage 89 communicating with the primary gas inlet port 52. An O-ring 90 provides a seal at the junction between the cap 51 and the body part 70.
The poppet valve assembly 79 comprises, as shown in Figure 6, a valve constituted by a body 91 housed partly in the body part 70 and partly in the cap 51. The body 91 has an inlet 92 at one end and an outlet 93 at the other and houses a ball 94 and spring 95 controlling flow through the body 91. The inlet 93 commun-cates in the cap 51 with the primary gas inlet port 52.
The poppet valve assembly further comprises an actuating poppet 96 slidable in a guide 97 and sealed by O-rings. The poppet 96 has a spigot that extends into the outlet 93 of the valve body 91 to engage the ball 94 to unseat the latter when the poppet is moved to the right as seen in Figure 6. When the ball 94 is so unseated, the by-pass passage 76 is placed in communication with the primary gas inlet port 52 via the chamber 78.
The patient valve further comprises a setting assembly (Figure 6) comprising a barrel 100 secured to the body part 70 so that its axis is offset from that of the poppet valve assembly 79, the axis of the latter being near to the internal wall of the barrel 100. The barrel 100 houses a valve sleeve 101 having a ring of ports 102 and is slidable in the barrel to bring the ports 102 into and out of register with corresponding ports 103 in the barrel. The sleeve 101 is restrained from rotation by a pin 104 in the barrel running in a slot in the sleeve. A spring 105 acts to urge the sleeve 101 to the left, as seen in the drawing, towards the position in which the ports 102 register with the ports 103.
The end of the sleeve 101 abuts the poppet 96 and the arrangement is such that when the sleeve is in the position shown, in which the ports 102 are out of register with the ports 103, the poppet is shifted to unseat-the ball 94 of the poppet valve assembly. Conversely, when the sleeve 101 is positioned to register its ports with those of the barrel 100, the ball 94 is allowed to seat to interrupt communication between the primary gas inlet port 52 and the by-pass passage 76.
The setting assembly further includes a knob 106 rotatable with respect to the barrel 100 and carrying a cam 107 that acts on a cross pin 108 on the valve sleeve 101 to shift this against the thrust of the spring 105.
The cam 107 is shaped to provide detent action to retain the knob in one or other of two relatively rotated positions, corresponding with the two required axially shifted positions of the valve sleeve 101.
The interior of the barrel 100 communicates, via a passage (not shown) in the body part 70, with the entrainment chamber 84 of the entrainment mixer. Thus, when the knob 106 is rotated to the position in which the valve sleeve ports 103 register with the barrel ports 102, the entrainment chamber 84 is placed in communication with the ambient atmosphere to enable diluent air to be drawn into the chamber 84 by entrainment action of the primary gas jet that issues from the nozzle 87 when a primary gas pulse is applied to the inlet port 52. In this setting of the knob 106, the poppet valve ball 94 is seated to prevent primary gas flow to the by-pass passage 76.
Thus the primary gas is diluted en route to the plenum 4 and thence to the patient.
In this realisation of the invention, as compared with the theoretical diagrams of Figures 2 and 3, the nozzle 87 of the entrainment mixer corresponds with the restrictor 21 of Figures 2 and 3; the poppet valve assembly 79 corresponds with the valve 23; and the barrel 100 and sleeve 101, with their respective parts 102, 103, correspond with the valve 24. The restrictor 22 of Figures 2 and 3 has no direct counterpart but its function of providing, in parallel with the nozzle 87, a flow path impedance between the primary gas inlet port 52 and the plenum 74 sufficient to produce the pressure drop required to shift the piston 59 to close the exhalation port 54, against the action of spring 55, is accomplished by the flow path impedance attributable to the poppet valve assembly 79.
For certain purposes a device that can assist a patient to breathe air of normal oxygen content can be preferred to a device capable only of delivering oxygen or oxygen-enriched air. A resuscitator/ventilator embodying the invention can be adapted very simply to provide for delivery of pulses of air for such purposes.
Thus, by substituting a source of compressed air for the described source of compressed oxygen, the control unit of such a resuscitator/ventilator would output air pulses, instead of oxygen pulses, to the patient valve. While such air pulses might be delivered direct to the patient, by the patient valve, in the same way as pure oxygen pulses would be delivered to the patient in one of the operating modes previously described, it is more advantageous to use the entrainment mixer to "dilute" the air delivered by the control unit, to provide the total breathable gas volume required, thereby minimising use of the compressed air source; In practice this means that a bottle of compressed air could provide for assisted breathing for a significant period, the air bottle supplying only about one third of the total breathing air required by the patient.
Moreover, because of the low demand on the compressed air source in such an operating mode, the compressed air source could be constituted by, for instance, a lightweight compressor capable of operation by a low power (e.g. 50 watt) electric motor drawing energy from a battery pack or umbilical lead to a vehicle battery to provide both portability and long term operation in the absence of bottled compressed air availability.
A A resuscitator/ventilator embodying the invention can also provide other useful facilities, based upon its capability of inducing the admixture of a gas at ambient pressure with a primary gas supplied at pressure to power the device.
Thus, for instance, the gas made available for entrainment may be oxygen or oxygenenriched air supplied, e.g., by an oxygen concentrator such as a molecular sieve concentrator. Accordingly the device may be caused to deliver to a patient a breathing gas consisting of oxygen-enriched air by being powered by compressed air as the primary gas and mixing this with oxygen or oxygen-enriched air, at about ambient pressure, supplied to the entrainment mixer of the patient valve. In a practical realisation of this operational possibility, and using a patient valve of the configuration described with reference to Figures 5 to 7, the ports 102 in the barrel 100 could be enclosed in a shroud fed with oxygen or oxygen-enriched air of su table oxygen content output by, say, a molecular sieve oxygen concentrator.
In like manner, a primary gas constituted by compressed air or oxygen might be "diluted" at the patient valve with an anaesthetic gas or vapour supplied in suitable form to be entrained in the primary gas.
Thus, in principle a resuscitator/ventilator device embodying the invention may be powered by any suitable primary gas available under the required pressure and, with the aid of the entrainment mixer of the patient valve, deliver to the patient that primary gas "diluted" with any other "diluent" gas or vapour available at ambient pressure or thereabouts: the diluent being, for example, one or more of air, oxygen, water vapour, anaesthetic gas or vapour.

Claims (11)

1. A gas-powered resusc-tator/ventilator device comprising a control unit having a highimpedance flow-regulation restriction adapted to output to a patient valve primary gas pulses appropriate for undiluted delivery to a patient, characterised by a patient valve including an entrainment mixer that when operative dilutes primary gas pulses output by the control unit, the patient valve and operative entrainment mixer jointly providing a primary gas flow impedance so related to the impedance of the flow-regulation restriction as to reduce primary gas flow therethrough.
2. A device according to claim 1, in which the primary gas flow impedance of the patient valve and operative entrainment mixer combination is so related to the impedance of the flow-regulation restriction as to reduce the primary gas flow therethrough in correspondence with the dilution thereof by the entrainment mixer.
3. A device according to claim 1 or 2, comprising a single patient valve incorporating an entrainment mixer that may be rendered operative or inoperative as required, by means that cause the impedance presented to primary gas flow to be appropriately raised when the entrainment mixer is rendered operative.
4. A gas-powered resuscitator/ventilator device comprising a control unit having a highimpedance flow-regulation restriction adapted to output to a patient valve primary gas pulses appropriate for undiluted delivery to a patient, characterised both by an entrainment mixer at the patient valve and in that the entrainment mixer is associated with a series flow restrictor and a shunt circuit and with ganged valve means oppositely controlling diluent flow to the entrainment mixer and primary gas flow in said shunt circuit respectively.
5. A device according to claim 4, in which the said series restrictor associated with the entrainment mixer is constituted by the nozzle thereof.
6. A device according to claim 4 or 5, in which the impedance of the shunt circuit and of the mixer and associated restrictor are so chosen that when the mixer is operative the impedance at the patient valve exceeds that obtaining when the mixer is disabled by an amount such that the primary gas flow to the patient valve is reduced in correspondence with the dilution of the primary gas to maintain a selected delivered gas volume.
7. A device according to any preceding claim, comprising a control unit adapted to deliver pulses of primary gas to a high-force patient valve.
8. A gas-powered resuscitator/ventilator device, substantially as described with reference to and as shown in Figures 2 and 3 of the accompanying drawings.
9. A gas-powered resuscitator/ventilator device, substantially as described with reference to and as shown in Figure 4 of the accompanying drawings.
10. For a gas-powered resuscitator/ventilator device comprising a control unit having a high-impedance flow-regulation restriction adapted to output primary gas pulses appropriate for undiluted delivery to a patient, a patient valve substantially as described with reference to and as shown in Figures 5 to 7 of the accompanying drawings.
11. Every novel feature and every novel combination of features disclosed herein.
GB08610169A 1985-05-02 1986-04-25 Resuscitator/ventilator Expired GB2174609B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08610169A GB2174609B (en) 1985-05-02 1986-04-25 Resuscitator/ventilator

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858511170A GB8511170D0 (en) 1985-05-02 1985-05-02 Resuscitator/ventilator
GB08610169A GB2174609B (en) 1985-05-02 1986-04-25 Resuscitator/ventilator

Publications (3)

Publication Number Publication Date
GB8610169D0 GB8610169D0 (en) 1986-05-29
GB2174609A true GB2174609A (en) 1986-11-12
GB2174609B GB2174609B (en) 1988-07-27

Family

ID=26289203

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08610169A Expired GB2174609B (en) 1985-05-02 1986-04-25 Resuscitator/ventilator

Country Status (1)

Country Link
GB (1) GB2174609B (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0691137A2 (en) 1994-07-05 1996-01-10 pneuPAC Limited Gas mixing devices for resuscitation/lung ventilation apparatus
WO1997013185A1 (en) * 1995-10-04 1997-04-10 Protector Technologies Limited Adjustable flow regulator device
GB2319588A (en) * 1995-10-04 1998-05-27 Protector Technologies Limited Adjustable flow regulator device
EP0878207A1 (en) * 1997-05-16 1998-11-18 Siemens-Elema AB Portable respiration apparatus
WO2000013731A1 (en) * 1998-09-04 2000-03-16 Caradyne (R & D) Limited A continuous positive airway pressure controller
WO2014162107A1 (en) 2013-04-04 2014-10-09 Smiths Medical International Limited Resuscitator arrangements and flow monitoring
US9675774B2 (en) 2009-04-02 2017-06-13 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles in free space
US9962512B2 (en) 2009-04-02 2018-05-08 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
US10058668B2 (en) 2007-05-18 2018-08-28 Breathe Technologies, Inc. Methods and devices for sensing respiration and providing ventilation therapy
US10099028B2 (en) 2010-08-16 2018-10-16 Breathe Technologies, Inc. Methods, systems and devices using LOX to provide ventilatory support
US10252020B2 (en) 2008-10-01 2019-04-09 Breathe Technologies, Inc. Ventilator with biofeedback monitoring and control for improving patient activity and health
US10265486B2 (en) 2009-09-03 2019-04-23 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US10792449B2 (en) 2017-10-03 2020-10-06 Breathe Technologies, Inc. Patient interface with integrated jet pump
US11154672B2 (en) 2009-09-03 2021-10-26 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8381729B2 (en) 2003-06-18 2013-02-26 Breathe Technologies, Inc. Methods and devices for minimally invasive respiratory support
US7588033B2 (en) 2003-06-18 2009-09-15 Breathe Technologies, Inc. Methods, systems and devices for improving ventilation in a lung area
EP1660004A4 (en) 2003-08-18 2017-05-31 Breathe Technologies, Inc. Method and device for non-invasive ventilation with nasal interface
CN101454041B (en) 2005-09-20 2012-12-12 呼吸科技公司 Systems, methods and apparatus for respiratory support of a patient
CA2652544A1 (en) 2006-05-18 2007-12-13 Breathe Technologies, Inc. Tracheostoma spacer, tracheotomy method, and device for inserting a tracheostoma spacer
CA2700869C (en) 2007-09-26 2018-10-30 Breathe Technologies, Inc. Methods and devices for treating sleep apnea
EP2200686A4 (en) 2007-09-26 2017-11-01 Breathe Technologies, Inc. Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
US8776793B2 (en) 2008-04-18 2014-07-15 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
EP2274036A4 (en) 2008-04-18 2014-08-13 Breathe Technologies Inc Methods and devices for sensing respiration and controlling ventilator functions
CA2734296C (en) 2008-08-22 2018-12-18 Breathe Technologies, Inc. Methods and devices for providing mechanical ventilation with an open airway interface
AU2011308548B2 (en) 2010-09-30 2014-10-23 Breathe Technologies, Inc. Methods, systems and devices for humidifying a respiratory tract

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2144334A (en) * 1983-08-02 1985-03-06 Bird F M Combination venturi jet and exhalation valve assembly

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2144334A (en) * 1983-08-02 1985-03-06 Bird F M Combination venturi jet and exhalation valve assembly

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0691137A2 (en) 1994-07-05 1996-01-10 pneuPAC Limited Gas mixing devices for resuscitation/lung ventilation apparatus
US5605148A (en) * 1994-07-05 1997-02-25 Pneupac Limited Gas mixing devices for resuscitation/lung ventilation apparatus
WO1997013185A1 (en) * 1995-10-04 1997-04-10 Protector Technologies Limited Adjustable flow regulator device
GB2319588A (en) * 1995-10-04 1998-05-27 Protector Technologies Limited Adjustable flow regulator device
GB2319588B (en) * 1995-10-04 1999-09-22 Protector Technologies Limited Adjustable flow regulator device
US6189531B1 (en) 1995-10-04 2001-02-20 Protector Technologies Bv Adjustable flow regulator device
EP0878207A1 (en) * 1997-05-16 1998-11-18 Siemens-Elema AB Portable respiration apparatus
US6095138A (en) * 1997-05-16 2000-08-01 Siemens Elema Ab Portable respiration apparatus, and system employing same
WO2000013731A1 (en) * 1998-09-04 2000-03-16 Caradyne (R & D) Limited A continuous positive airway pressure controller
US6634356B1 (en) 1998-09-04 2003-10-21 Caradyne (R&D) Limited Continuous positive airway pressure controller
US10058668B2 (en) 2007-05-18 2018-08-28 Breathe Technologies, Inc. Methods and devices for sensing respiration and providing ventilation therapy
US10252020B2 (en) 2008-10-01 2019-04-09 Breathe Technologies, Inc. Ventilator with biofeedback monitoring and control for improving patient activity and health
US9962512B2 (en) 2009-04-02 2018-05-08 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
US10695519B2 (en) 2009-04-02 2020-06-30 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within nasal pillows
US9675774B2 (en) 2009-04-02 2017-06-13 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles in free space
US11896766B2 (en) 2009-04-02 2024-02-13 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation with gas delivery nozzles in free space
US10232136B2 (en) 2009-04-02 2019-03-19 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation for treating airway obstructions
US11707591B2 (en) 2009-04-02 2023-07-25 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles with an outer tube
US11103667B2 (en) 2009-04-02 2021-08-31 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation with gas delivery nozzles in free space
US10046133B2 (en) 2009-04-02 2018-08-14 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation for providing ventilation support
US10709864B2 (en) 2009-04-02 2020-07-14 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles with an outer tube
US10265486B2 (en) 2009-09-03 2019-04-23 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US11154672B2 (en) 2009-09-03 2021-10-26 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US10099028B2 (en) 2010-08-16 2018-10-16 Breathe Technologies, Inc. Methods, systems and devices using LOX to provide ventilatory support
WO2014162107A1 (en) 2013-04-04 2014-10-09 Smiths Medical International Limited Resuscitator arrangements and flow monitoring
US10792449B2 (en) 2017-10-03 2020-10-06 Breathe Technologies, Inc. Patient interface with integrated jet pump

Also Published As

Publication number Publication date
GB8610169D0 (en) 1986-05-29
GB2174609B (en) 1988-07-27

Similar Documents

Publication Publication Date Title
US4682591A (en) Resuscitator/ventilator
GB2174609A (en) Resuscitator/ventilator
JP3386138B2 (en) Oxygen storage regulator device
EP0831950B1 (en) Pneumatically-operated gas demand apparatus
US6378520B1 (en) Variable pressure and flow control for a pneumatically-operated gas demand apparatus
EP0691137B1 (en) Gas mixing devices for resuscitation/lung ventilation apparatus
US7617824B2 (en) Ventilator adaptable for use with either a dual-limb circuit or a single-limb circuit
US3234932A (en) Respirator
US4702240A (en) Demand-responsive gas blending system for medical ventilator
EP0451090B1 (en) Resuscitation and ventilation device
US6237594B1 (en) Pneumatically-operated gas demand apparatus
US6612307B2 (en) Oxygen conserver
US4249528A (en) Manual respirator apparatus for use with automatic respirators
GB1582368A (en) Ventilator
US20240100289A1 (en) Gas Mixing System for Medical Ventilator
US4702242A (en) Respirator and/or anesthesia supply apparatus
CN102114296A (en) Breathing machine, two-path gases mixing control mechanism, and adjusting method
US4056099A (en) Volumetric respiration equipment
US3815593A (en) Static respirator for artificial respiration
CN109481804B (en) Breathing machine
JPS5940867A (en) Resuscitator
GB2076676A (en) Gas mixing apparatus
CS211460B1 (en) Pneumatically controlled respirating instrument
US11294404B1 (en) Air-oxygen blender with periodic pressure venting
US20030127099A1 (en) Demand valve which can be used in oxygen therapy

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 20060424